Skip to main content

Adtalem Global Education Inc

For the period ended Mar 31, 2024. Filed May 2, 2024.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Mar 31, 2024 · Filed May 2, 2024

CVSA$110.32-2.3%Stored close · as of Nov 6, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Earnings per Share

  1. Earnings per Share

As further described in Note 14 “Share Repurchases,” on March 14, 2022, we entered into an accelerated share repurchase (“ASR”) agreement to repurchase $150.0 million of common stock. For purposes of calculating earnings per share, Adtalem reflected the ASR agreement as a repurchase of Adtalem common stock and as a forward contract indexed to its own common stock. Based on the volume-weighted average price of Adtalem’s common stock per the terms of the ASR agreement, common stock of 102 thousand shares were contingently issuable by Adtalem under the ASR agreement and were included in the diluted earnings per share calculation for the nine months ended March 31, 2023 because the effect would have been dilutive. As of October 14, 2022, the ASR agreement is no longer outstanding. Diluted earnings per share was computed using the treasury stock method for stock awards. Certain shares related to stock awards were excluded from the computation of earnings per share because the effect would have been antidilutive. The following table sets forth the computations of basic and diluted earnings per share and antidilutive shares (in thousands, except per share data):

​​​​​​​​​​​​​
​ · ​ · Three Months Ended · ​ · Nine Months Ended
​ · ​ · March 31, · ​ · March 31,
​ · ​ · 2024 · ​ · 2023 · ​ · 2024 · ​ · 2023
Numerator:​​​​​​​​​​​​
Net income (loss): · ​ · ​ · ​ · ​ · ​ · ​ · ​ · ​
Continuing operations​$37,441​$48,563​$87,113​$78,202
Discontinued operations​​(620)​​(2,694)​​245​​(7,088)
Net income​$36,821​$45,869​$87,358​$71,114
​​​​​​​​​​​​​
Denominator:​​​​​​​​​​​​
Weighted-average basic shares outstanding​38,713​45,125​40,000​45,276
Effect of dilutive stock awards​923​676​874​711
Effect of ASR​—​—​—​102
Weighted-average diluted shares outstanding​39,636​45,801​40,874​46,089
​​​​​​​​​​​​​
Earnings (loss) per share:​​​​​​​​​​​​
Basic:​​​​​​​​​​​​
Continuing operations​$0.97​$1.08​$2.18​$1.73
Discontinued operations​$(0.02)​$(0.06)​$0.01​$(0.16)
Total basic earnings per share​$0.95​$1.02​$2.18​$1.57
Diluted:​​​​​​​​​​​​
Continuing operations​$0.94​$1.06​$2.13​$1.70
Discontinued operations​$(0.02)​$(0.06)​$0.01​$(0.15)
Total diluted earnings per share​$0.93​$1.00​$2.14​$1.54
​​​​​​​​​​​​​
Weighted-average antidilutive shares​​2​​429​​141​​424
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.